Back to search
FDAFDA · Food and drugs·Recall number D-0599-2021

Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India, NDC 55111-121-05.

Published June 2, 2021 · Recall initiated: May 4, 2021

Summary

FDA records drug Class III recall D-0599-2021, published June 2, 2021 and initiated May 4, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 2980 500 count -bottles; Lot: Lot # C905063, Exp 07/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

What to do

Voluntary: Firm initiated · Letter

Get an email if ATORVASTATIN CALCIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATORVASTATIN CALCIUM
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Distributed Nationwide in the USA
UPC
0355111123903
Lot
Lot # C905063, Exp 07/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India, NDC 55111-121-05. recalled?

Yes. FDA published recall D-0599-2021 on June 2, 2021. Reported hazard: Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0355111123903.